Short answer · Medically reviewed summary · Last updated: 2026-05-08
Small Intestine Bacterial Overgrowth (SIBO) does not have a unique, dedicated ICD-10 or ICD-9 code. Instead, clinicians typically use ICD-10 code K63.89 (Other specified diseases of intestine) or ICD-9 code 579.8 (Other specified intestinal malabsorption) to document the condition for billing and diagnostic purposes. How is Small Intestine Bacterial Overgrowth (SIBO) classified for billing? Because Small Intestine Bacterial Overgrowth (SIBO) is a clinical manifestation of underlying dysmotility or anatomical issues rather than a primary distinct disease entity, it lacks a specific diagnostic code.
Small Intestine Bacterial Overgrowth (SIBO) does not have a unique, dedicated ICD-10 or ICD-9 code. Instead, clinicians typically use ICD-10 code K63.89 (Other specified diseases of intestine) or ICD-9 code 579.8 (Other specified intestinal malabsorption) to document the condition for billing and diagnostic purposes.
Because Small Intestine Bacterial Overgrowth (SIBO) is a clinical manifestation of underlying dysmotility or anatomical issues rather than a primary distinct disease entity, it lacks a specific diagnostic code. Medical coders often use codes related to malabsorption or intestinal dysfunction. When documenting Small Intestine Bacterial Overgrowth (SIBO), physicians must often supplement these codes with additional identifiers for the primary cause, such as motility disorders or structural abnormalities, to ensure insurance coverage and accurate clinical records.
Patients with Small Intestine Bacterial Overgrowth (SIBO) frequently report a constellation of gastrointestinal symptoms that significantly impact quality of life. The 30 community members on DiseaseMaps.org frequently discuss the following hallmark symptoms:
While the ICD codes provide a framework for billing, the diagnosis of Small Intestine Bacterial Overgrowth (SIBO) is clinical. The gold standard remains a jejunal aspirate and culture, though this is invasive. Most clinical settings rely on non-invasive breath tests, specifically the lactulose or glucose hydrogen/methane breath test, to detect the metabolic byproducts of bacterial fermentation in the small intestine.
Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician regarding a medical condition.